WO2000046243A1 - Process for preparing coagulants for water treatment - Google Patents

Process for preparing coagulants for water treatment Download PDF

Info

Publication number
WO2000046243A1
WO2000046243A1 PCT/IB2000/000164 IB0000164W WO0046243A1 WO 2000046243 A1 WO2000046243 A1 WO 2000046243A1 IB 0000164 W IB0000164 W IB 0000164W WO 0046243 A1 WO0046243 A1 WO 0046243A1
Authority
WO
WIPO (PCT)
Prior art keywords
protein
process according
slurry
solution
water
Prior art date
Application number
PCT/IB2000/000164
Other languages
French (fr)
Inventor
Patrick Sellier
Original Assignee
Optima Environnement Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Optima Environnement Sa filed Critical Optima Environnement Sa
Priority to AU23150/00A priority Critical patent/AU2315000A/en
Publication of WO2000046243A1 publication Critical patent/WO2000046243A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C12P21/02—Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
    • C—CHEMISTRY; METALLURGY
    • C02—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
    • C02F—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
    • C02F1/00—Treatment of water, waste water, or sewage
    • C02F1/52—Treatment of water, waste water, or sewage by flocculation or precipitation of suspended impurities
    • C02F1/54—Treatment of water, waste water, or sewage by flocculation or precipitation of suspended impurities using organic material
    • C02F1/56—Macromolecular compounds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/415—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from plants
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins

Definitions

  • the present invention relates to a process for preparing proteins that can act as effective coagulants in the treatment and purification of contaminated water.
  • it relates to a process for extracting coagulant protein derivatives from the seeds of trees within the family Moringaceae and especially those of Moringa oleifera Lam (syns Moringa pterygosperma Gaertn.).
  • Moringa The seeds of Moringa oleifera Lam (hereinafter referred to as Moringa) are utilised primarily to obtain an edible oil, which may be extracted using a mechanical press.
  • the residue from this extraction process is known as presscake.
  • the seeds of Moringa contain water soluble, low molecular weight, highly basic proteins that can act as coagulants in contaminated water treatment.
  • the crushed/powdered seed suspensions and presscake, which remains following oil extraction, have been found to be effective coagulants but they suffer from the disadvantage that they result in a large amount of residual insoluble material which requires disposing of.
  • the object of the present invention is to provide an extraction process which results in a useful yield of coagulation proteins from Moringa seeds.
  • the extraction process should preferably, but not exclusively, be suitable for use in less developed countries thereby providing inexpensive coagulant proteins for water treatment.
  • a process for preparing coagulation proteins from Moringa seeds which comprises the steps of:
  • salts for example, ammonium salts, or alkali, e.g. sodium hydroxide, ammonium hydroxide, or a combination thereof;
  • the process preferably comprises the additional step of drying the protein slurry to a moisture content of 15% or less, preferably 10% or less, most preferably 5% or less.
  • the preferred alkali for precipitating the proteins from the acid extract is sodium hydroxide.
  • sodium hydroxide it is preferred to wash the protein precipitate in step (5) of the process to produce a slurry having a lower pH, preferably a pH of less than 8.
  • a coagulation protein preparation suitable for use in the purification of water when prepared according to the process as described above.
  • the extraction process comprises a series of unit operations, each designed to perform an essential step in the extraction of proteins, and their conversion into a state for practical use, from the seeds of the Moringa tree.
  • Figure 1 is a schematic drawing of the first part of the process.
  • Figure 2 is a schematic drawing of the second part of the process.
  • the presscake is received as an unevenly sized, randomly agglomerated granular material.
  • This operation consists of a feed hopper (1) from which the presscake is fed at a controlled rate into a mill (2) suitable for milling the presscake into a granular powder.
  • the mill achieves size reduction by its cutting action.
  • Product is fed to the centre of a high speed impellor where centrifugal force moves it to the impellor tips which propel it tangentially against a cylindrical stationary cutting head.
  • the mill is designed for either dry operation or wet operation in which the product is suspended in water or in which water is directed into the mill when necessary to dislodge deposits of the product.
  • On leaving the mill the presscake has been converted to an evenly divided granular powder of a particle size, typically 0.5-2.5 mm diameter, preferably 1-2 mm diameter, and with a minimum of very fine particles which would reduce the efficiency of a later separation operation.
  • the milled product is collected in a receiving hopper (3) incorporating an exhaust duct for the airflow induced by the mill.
  • the receiving hopper has a device such as a rotary valve (3a) to facilitate discharge of the product into containers or onto a conveyor (4) for transport to the extraction operations.
  • This consists of one or more process vessels (5) and a facility (7) for preparing and storing hydrochloric acid.
  • the process vessel is typically a vertical cylindrical tank with a base sloping to a discharge outlet and equipped with a mixer (6) employing a propeller or dispersion type rotating agitator.
  • the tank is filled with water and hydrochloric acid to provide a solution of a specified strength, from 0.05 M to 0.2 M, typically 0.1 M or 0.37% w/w.
  • the milled presscake is added to this solution in a specified proportion, typically w/w and thoroughly dispersed before leaving to infuse for at least one hour up to one day.
  • protein is leached out of the presscake as an acidic solution.
  • This operation separates the acidic protein solution from the insoluble residue of the presscake now referred to as spent cake.
  • the spent cake is a by-product from the main process.
  • the acid protein solution may be separated from the insoluble residue by settlement, settlement and filtration or centrifugation. Separation is most effectively achieved by use of a centrifuge (9) but a clarification filter has also been used.
  • the acid protein solution and insoluble residue are pumped using a pump (8) to the centrifuge (9).
  • the preferred centrifuge is a continuous disk-stack type commonly used in the food and drink industry for separation of suspended solids from liquids and discharges the separated solids as a sludge.
  • An impellor pump may be incorporated into the rotor which discharges the clear protein solution at sufficient pressure to assist transfer by pipeline to a holding vessel (10) where it is referred to as the acidic liquor.
  • This operation recovers the protein from the acidic liquor by converting the liquor to an alkaline solution in which the protein is insoluble.
  • the alkali which may be used to achieve this is sodium hydroxide and a facility (12) is provided for preparation and storage of concentrated solution in water, typically 4% w/v. When required, this concentrated solution is added to the acidic liquor in the proportion typically of 12.5% v/v to achieve a pH of from 10.5 - 11.5.
  • Precipitation is rapid and the addition of the concentrated alkali may be achieved in a process vessel equipped with a dispersing mixer (similar to (5) plus (6)) or preferably using an in-line mixer (14) through which the acidic liquor is continuously pumped by pump (11).
  • the alkali is continuously dosed (13) into the acid liquor before the mixer at an automatically controlled rate to achieve the specified proportion.
  • the resultant liquor is discharged as an alkaline slurry into one or more holding vessels (15) intended to act as break tanks or buffer capacity for the pump transferring this dilute slurry to the next operation.
  • Some sedimentation occurs in the holding vessel and advantage may be taken of this to decant a part of the clear liquid away to waste reception. However, it is significant that the residence time must be limited preferably to less than two hours to avoid degradation of the protein.
  • Precipitation may alternatively be carried out using an ammonium salt such as ammonium sulphate.
  • the preferred method is to use one or more continuous disk-stack centrifuges designed to separate solids from liquid suspensions and discharge them in the form of a thick slurry, typically having a solids content in the range of 5-25%, preferably 10-20%, most preferably 15-20%.
  • the dilute slurry is transferred by a pump (16) via a screen (17) for the purpose of removing any relatively gross particles which it is known might cause a blockage in the subsequent process equipment.
  • the dilute slurry is thereby transferred to the centrifuges arranged in the form of a multistage operation.
  • the first stage centrifuge (18) separates the protein as a thick slurry from the residual clear alkaline liquor which is discharged to waste or other recovery location.
  • the thick slurry is continuously mixed with water or clear liquor from a subsequent stage, and then further separated by centrifuge (19) as a thick slurry but with a part of the original alkaline liquor thus washed out.
  • a wash stage this is repeated using fresh water (20) to wash out the alkaline liquor and so reduce the pH of the thick slurry to a preferred level of less than 8.
  • the additional wash stages may be achieved with one centrifuge by using intermediate batch holding vessels.
  • a series of interlinked centrifuges as described in what is commonly referred to as a countercurrent washing system.
  • the finally recovered slurry has a solids content suitable for the next operation which, typically requires it in the range of 15-20%.
  • a positive displacement pump (21) transfers the slurry to a holding vessel (22) which acts as a buffer storage necessary to facilitate a controlled unbroken supply to the next operation.
  • the protein in the state of a thick slurry is available for immediate use (as a water treatment aid).
  • a water treatment aid it must be assumed that in the form of a large scale efficient factory, it will be remote from the various points of use of the protein.
  • the state of the protein is changed to that of a dry powder in which it is resistant to degradation, and is convenient for storage, transport and use.
  • This operation includes a system for drying the thick slurry to a moisture content preferably 15% or less, and producing the protein in a finely divided form for convenience of use.
  • Freeze drying is a method which dries the protein to a friable solid which breaks up to a fine granular state.
  • the preferred method is spray-drying which dries the protein without unwanted degradation and simultaneously converts it to a fine powder.
  • the spray dryer (24) consists of a chamber into which the slurry is fed at a controlled rate by a positive displacement variable capacity pump (23).
  • the slurry is dispersed in the chamber in the form of very small droplets by means of an atomiser nozzle or atomiser rotating disk.
  • a large volume of air is simultaneously introduced which has been heated to a temperature, typically of 200°C.
  • the method achieves a rapid rate of evaporation of the water component of the slurry without raising the product temperature to a damaging level and for this protein the discharge temperature is limited to 100°C or less, preferably a range of 80°-90°, most preferably a range of 84-87°C.
  • the physical properties of the dry protein powder are such that it is attracted to and clings to the inside walls of the spray dryer chamber and to the exit ducts and receiver cyclone chamber (25).
  • the spray dryer is equipped with devices to dislodge the powder and to ensure that it remains suspended in the flowing air.
  • the final product is discharged at two available locations (26) from the spray drying system via a rotary valve (26a) or similar method, from which it is filled directly into containers for transport or into a conveyor system for transfer to a filling process.
  • Milled Moringa seed presscake (65kg) was added to an extract solution (2600 1) consisting of 0.1 M hydrochloric acid in water.
  • the resultant dispersion was stirred for a minimum of 1 hour prior to the residual solids being removed by centrifugation. This resulted in the recovery of 2200 1 of supernatant containing solubilised protein.
  • To the supernatant has added a 4% w/v sodium hydroxide solution (275 1, 12.5%v/v).
  • the alkali mixture was then centrifuged to remove the precipitated protein.
  • the resultant slurry was then spray dried giving 3kg of dry protein product suitable for use for water treatment.
  • Moringa 1 was an extract produced using 100 mM HC1 as extractant and 1 M NaOH as precipitant.
  • Moringa 2 was an extract prepared according to the invention using ammonium sulphate precipitation.
  • a test raw water was prepared utilising kaolin clay in deionised water with an ionic background provided by sodium bicarbonate.
  • Stock kaolin suspensions for dilution in the test water were prepared using the following procedure: 200g samples of Kaolin (BDH, Grade light, particle size 0.4 - l ⁇ m) were mixed to a paste and gradually diluted with deionised water, containing 450mg/l sodium bicarbonate, to a final volume of 1 litre. Samples were then rapid mixed for 2 hours at 300 rpm, allowed to settle for 1 hour following which the top 800 ml was decanted. This was then made up to 1 litre again with deionised water/sodium bicarbonate and mixed for a further 2 hours at 300 rpm. Following settlement for 1 hour the top 800ml was decanted and used as a stock solution for dilution to the required turbidity. An initial turbidity of 300+ 10 NTU was selected as the experimental standard. 3. Test Procedure
  • Figure 3 demonstrates comparative performance between Moringa 1 and 2 using the standard test water and test procedure described above. Both preparations showed good turbidity removal at comparatively low doses. For this test water Moringa 1 provided marginally better turbidity removal than Moringa 2, however, the optimum dose was lower for Moringa 2, viz 4mg/l as compared to 6mg/l.
  • Figure 4 demonstrates comparative performance on a natural raw water obtained from the Ruvu river in Africa. A similar trend to that observed in Figure 1 was achieved.

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Microbiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biotechnology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Hydrology & Water Resources (AREA)
  • Environmental & Geological Engineering (AREA)
  • Water Supply & Treatment (AREA)
  • Botany (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Medicinal Chemistry (AREA)
  • Peptides Or Proteins (AREA)

Abstract

This invention relates to a process for preparing proteins that can act as effective coagulants in the treatment and purification of contaminated water. In particular, the invention relates to a process for extracting coagulant protein derivatives from the seeds of trees from the family Moringaceae. The invention also relates to coagulation protein preparations prepared by the process, and the use of such preparations for the treatment and purification of contaminated water.

Description

PROCESS FOR PREPARING COAGULANTS FOR WATER TREATMENT
The present invention relates to a process for preparing proteins that can act as effective coagulants in the treatment and purification of contaminated water. In particular it relates to a process for extracting coagulant protein derivatives from the seeds of trees within the family Moringaceae and especially those of Moringa oleifera Lam (syns Moringa pterygosperma Gaertn.).
The seeds of Moringa oleifera Lam (hereinafter referred to as Moringa) are utilised primarily to obtain an edible oil, which may be extracted using a mechanical press. The residue from this extraction process is known as presscake. It has been found that the seeds of Moringa contain water soluble, low molecular weight, highly basic proteins that can act as coagulants in contaminated water treatment. The crushed/powdered seed suspensions and presscake, which remains following oil extraction, have been found to be effective coagulants but they suffer from the disadvantage that they result in a large amount of residual insoluble material which requires disposing of.
The object of the present invention is to provide an extraction process which results in a useful yield of coagulation proteins from Moringa seeds. The extraction process should preferably, but not exclusively, be suitable for use in less developed countries thereby providing inexpensive coagulant proteins for water treatment.
According to one aspect of the invention there is provided a process for preparing coagulation proteins from Moringa seeds which comprises the steps of:
1. treating Moringa seed presscake and/or whole seed inclusive of shell to produce an evenly divided granular powder having, for example, a particle size of from 0.5 to 2.5 mm diameter; and 2. adding the granular presscake to hydrochloric acid, preferably a solution of from 0.05 M to 0.2 M hydrochloric acid, and leaving the resultant dispersion to infuse for at least 1 hour and up to 24 hours; and
3. separating the acid protein solution from the insoluble residue of the presscake; and
4. precipitating the proteins from the acid extract using salts, for example, ammonium salts, or alkali, e.g. sodium hydroxide, ammonium hydroxide, or a combination thereof; and
5. separating the protein precipitate to produce a slurry.
The process preferably comprises the additional step of drying the protein slurry to a moisture content of 15% or less, preferably 10% or less, most preferably 5% or less.
The preferred alkali for precipitating the proteins from the acid extract is sodium hydroxide. When sodium hydroxide is used it is preferred to wash the protein precipitate in step (5) of the process to produce a slurry having a lower pH, preferably a pH of less than 8.
According to a second aspect of the invention there is provided a coagulation protein preparation suitable for use in the purification of water when prepared according to the process as described above.
According to yet another aspect there is provided the use of such a coagulation protein precipitation for the treatment and purification of contaminated water. The extraction process comprises a series of unit operations, each designed to perform an essential step in the extraction of proteins, and their conversion into a state for practical use, from the seeds of the Moringa tree.
The process will be further described with reference to the accompanying figures in which:
Figure 1 is a schematic drawing of the first part of the process; and
Figure 2 is a schematic drawing of the second part of the process.
The unit operations of the process are taken in sequence.
A. Size Reduction
The presscake is received as an unevenly sized, randomly agglomerated granular material.
This operation consists of a feed hopper (1) from which the presscake is fed at a controlled rate into a mill (2) suitable for milling the presscake into a granular powder.
The mill achieves size reduction by its cutting action. Product is fed to the centre of a high speed impellor where centrifugal force moves it to the impellor tips which propel it tangentially against a cylindrical stationary cutting head. The mill is designed for either dry operation or wet operation in which the product is suspended in water or in which water is directed into the mill when necessary to dislodge deposits of the product. On leaving the mill the presscake has been converted to an evenly divided granular powder of a particle size, typically 0.5-2.5 mm diameter, preferably 1-2 mm diameter, and with a minimum of very fine particles which would reduce the efficiency of a later separation operation. The milled product is collected in a receiving hopper (3) incorporating an exhaust duct for the airflow induced by the mill. The receiving hopper has a device such as a rotary valve (3a) to facilitate discharge of the product into containers or onto a conveyor (4) for transport to the extraction operations.
B. Acid Extraction
This consists of one or more process vessels (5) and a facility (7) for preparing and storing hydrochloric acid.
The process vessel is typically a vertical cylindrical tank with a base sloping to a discharge outlet and equipped with a mixer (6) employing a propeller or dispersion type rotating agitator.
In operation, the tank is filled with water and hydrochloric acid to provide a solution of a specified strength, from 0.05 M to 0.2 M, typically 0.1 M or 0.37% w/w. The milled presscake is added to this solution in a specified proportion, typically
Figure imgf000006_0001
w/w and thoroughly dispersed before leaving to infuse for at least one hour up to one day. During this operation, protein is leached out of the presscake as an acidic solution.
C. Clarification of Acidic Solution
This operation separates the acidic protein solution from the insoluble residue of the presscake now referred to as spent cake.
The spent cake is a by-product from the main process.
The acid protein solution may be separated from the insoluble residue by settlement, settlement and filtration or centrifugation. Separation is most effectively achieved by use of a centrifuge (9) but a clarification filter has also been used. The acid protein solution and insoluble residue are pumped using a pump (8) to the centrifuge (9).
The preferred centrifuge is a continuous disk-stack type commonly used in the food and drink industry for separation of suspended solids from liquids and discharges the separated solids as a sludge. An impellor pump may be incorporated into the rotor which discharges the clear protein solution at sufficient pressure to assist transfer by pipeline to a holding vessel (10) where it is referred to as the acidic liquor.
D. Protein Precipitation
This operation recovers the protein from the acidic liquor by converting the liquor to an alkaline solution in which the protein is insoluble. The alkali which may be used to achieve this is sodium hydroxide and a facility (12) is provided for preparation and storage of concentrated solution in water, typically 4% w/v. When required, this concentrated solution is added to the acidic liquor in the proportion typically of 12.5% v/v to achieve a pH of from 10.5 - 11.5.
Precipitation is rapid and the addition of the concentrated alkali may be achieved in a process vessel equipped with a dispersing mixer (similar to (5) plus (6)) or preferably using an in-line mixer (14) through which the acidic liquor is continuously pumped by pump (11). In this system the alkali is continuously dosed (13) into the acid liquor before the mixer at an automatically controlled rate to achieve the specified proportion. The resultant liquor is discharged as an alkaline slurry into one or more holding vessels (15) intended to act as break tanks or buffer capacity for the pump transferring this dilute slurry to the next operation.
Some sedimentation occurs in the holding vessel and advantage may be taken of this to decant a part of the clear liquid away to waste reception. However, it is significant that the residence time must be limited preferably to less than two hours to avoid degradation of the protein.
Precipitation may alternatively be carried out using an ammonium salt such as ammonium sulphate.
£. Separation of the Protein from the Dilute Slurry
Separation by filtration whilst found applicable is made difficult by the coagulant nature of the suspended protein tending to cause a phenomenon known as blinding of the filter medium. This is to be avoided as it is important to complete the recovery of the protein from the dilute slurry without excessive delay.
The preferred method is to use one or more continuous disk-stack centrifuges designed to separate solids from liquid suspensions and discharge them in the form of a thick slurry, typically having a solids content in the range of 5-25%, preferably 10-20%, most preferably 15-20%.
The dilute slurry is transferred by a pump (16) via a screen (17) for the purpose of removing any relatively gross particles which it is known might cause a blockage in the subsequent process equipment. The dilute slurry is thereby transferred to the centrifuges arranged in the form of a multistage operation.
The first stage centrifuge (18) separates the protein as a thick slurry from the residual clear alkaline liquor which is discharged to waste or other recovery location. In the next stage, the thick slurry is continuously mixed with water or clear liquor from a subsequent stage, and then further separated by centrifuge (19) as a thick slurry but with a part of the original alkaline liquor thus washed out. Known as a wash stage, this is repeated using fresh water (20) to wash out the alkaline liquor and so reduce the pH of the thick slurry to a preferred level of less than 8. Alternatively, the additional wash stages may be achieved with one centrifuge by using intermediate batch holding vessels. For continuous and efficient production it is preferable to use a series of interlinked centrifuges as described in what is commonly referred to as a countercurrent washing system.
The finally recovered slurry has a solids content suitable for the next operation which, typically requires it in the range of 15-20%. A positive displacement pump (21) transfers the slurry to a holding vessel (22) which acts as a buffer storage necessary to facilitate a controlled unbroken supply to the next operation.
F. Drying
If the process is conveniently located, the protein in the state of a thick slurry is available for immediate use (as a water treatment aid). However, it must be assumed that in the form of a large scale efficient factory, it will be remote from the various points of use of the protein. For this major purpose, the state of the protein is changed to that of a dry powder in which it is resistant to degradation, and is convenient for storage, transport and use.
This operation includes a system for drying the thick slurry to a moisture content preferably 15% or less, and producing the protein in a finely divided form for convenience of use.
Freeze drying is a method which dries the protein to a friable solid which breaks up to a fine granular state. The preferred method is spray-drying which dries the protein without unwanted degradation and simultaneously converts it to a fine powder. The spray dryer (24) consists of a chamber into which the slurry is fed at a controlled rate by a positive displacement variable capacity pump (23). The slurry is dispersed in the chamber in the form of very small droplets by means of an atomiser nozzle or atomiser rotating disk. A large volume of air is simultaneously introduced which has been heated to a temperature, typically of 200°C. The method achieves a rapid rate of evaporation of the water component of the slurry without raising the product temperature to a damaging level and for this protein the discharge temperature is limited to 100°C or less, preferably a range of 80°-90°, most preferably a range of 84-87°C.
The physical properties of the dry protein powder are such that it is attracted to and clings to the inside walls of the spray dryer chamber and to the exit ducts and receiver cyclone chamber (25). The spray dryer is equipped with devices to dislodge the powder and to ensure that it remains suspended in the flowing air.
The final product is discharged at two available locations (26) from the spray drying system via a rotary valve (26a) or similar method, from which it is filled directly into containers for transport or into a conveyor system for transfer to a filling process.
The invention will be further described with reference to the following examples :-
EXAMPLE 1
Preparation of Coagulation protein from Morinea
Milled Moringa seed presscake (65kg) was added to an extract solution (2600 1) consisting of 0.1 M hydrochloric acid in water. The resultant dispersion was stirred for a minimum of 1 hour prior to the residual solids being removed by centrifugation. This resulted in the recovery of 2200 1 of supernatant containing solubilised protein. To the supernatant has added a 4% w/v sodium hydroxide solution (275 1, 12.5%v/v). The alkali mixture was then centrifuged to remove the precipitated protein. The resultant slurry was then spray dried giving 3kg of dry protein product suitable for use for water treatment.
EXAMPLE 2
Comparison of Water Treatment Using Moringa Proteins
Materials and Methods
1. Protein Preparations
Two preparations of Moringa seed proteins were made, Moringa 1 and Moringa 2. Moringa 1 was an extract produced using 100 mM HC1 as extractant and 1 M NaOH as precipitant. Moringa 2 was an extract prepared according to the invention using ammonium sulphate precipitation.
2. Test Water
A test raw water was prepared utilising kaolin clay in deionised water with an ionic background provided by sodium bicarbonate. Stock kaolin suspensions for dilution in the test water were prepared using the following procedure: 200g samples of Kaolin (BDH, Grade light, particle size 0.4 - lμm) were mixed to a paste and gradually diluted with deionised water, containing 450mg/l sodium bicarbonate, to a final volume of 1 litre. Samples were then rapid mixed for 2 hours at 300 rpm, allowed to settle for 1 hour following which the top 800 ml was decanted. This was then made up to 1 litre again with deionised water/sodium bicarbonate and mixed for a further 2 hours at 300 rpm. Following settlement for 1 hour the top 800ml was decanted and used as a stock solution for dilution to the required turbidity. An initial turbidity of 300+ 10 NTU was selected as the experimental standard. 3. Test Procedure
A standard jar test procedure was used for all testing - viz fast mix at 300rpm for 2 minutes following coagulant addition; slow mix at 30rpm for 15 minutes; 1 hour quiescent settling. Turbidity samples were taken from 2 cm below the surface of the treated water following the settling period. pH of the treated water was taken when considered necessary.
Results
Figure 3 demonstrates comparative performance between Moringa 1 and 2 using the standard test water and test procedure described above. Both preparations showed good turbidity removal at comparatively low doses. For this test water Moringa 1 provided marginally better turbidity removal than Moringa 2, however, the optimum dose was lower for Moringa 2, viz 4mg/l as compared to 6mg/l.
Figure 4 demonstrates comparative performance on a natural raw water obtained from the Ruvu river in Tanzania. A similar trend to that observed in Figure 1 was achieved.

Claims

1. A process for preparing coagulant proteins from seeds of trees of the family Moringaceae, which process comprises the steps of a) treating seed presscake or whole seed to produce an evenly divided granular powder; b) adding the granular powder from (a) to a solution of hydrochloric acid and leaving the resultant dispersion to infuse; c) separating the acid protein solution from the insoluble residue; d) precipitating the proteins from the acid solution using alkali, ammonium salts or a combination thereof; e) separating the protein precipitate to produce a slurry.
2. The process according to Claim 1, which comprises the additional step of drying the protein slurry to a moisture content of 15% or less.
3. The process according to Claim 1 or Claim 2, wherein the seeds are derived from Moringa oleifera lam.
4. The process according to any one of Claims 1 to 3, wherein the granular powder has a particle size of from 0.5 to 2.5 mm diameter.
5. The process according to Claim 4, wherein the granular powder has a particle size of from 1 to 2 mm diameter.
6. The process according to any one of Claims 1 to 5, wherein the concentration of hydrochloric acid solution is from 0.05 m to 0.2 M.
7. The process according to Claim 6, wherein the concentration of hydrochloric acid solution is 0.1 M.
8. The process according to any one of Claims 1 to 7, wherein in step (b) the dispersion is infused for at least one hour and up to 24 hours.
9. The process according to any one of Claims 1 to 8, wherein the acid protein solution is separated from the insoluble residue by centrifugation or clarification filtration.
10. The process according to any one of Claims 1 to 9, wherein the protein is precipitated from the acid solution using sodium hydroxide, ammonium hydroxide, ammonium sulphate or a combination thereof.
11. The process according to claim 10, wherem the protein is precipitated using sodium hydroxide.
12. The process according to claim 11, wherein in step (e) the precipitate is washed to produce a slurry having a pH of less than 8.
13. The process according to any one of Claims 2 to 12, wherein protein slurry is spray-dried.
14. The process according to any one of Claims 2 to 12, wherein the protein slurry is freeze-dried.
15. A coagulation protein preparation suitable for use in the purification of water when prepared according to the process claimed in any one of Claims 1 to
14.
16. Use of a protein preparation according to Claim 15, for the treatment and purification of contaminated water.
PCT/IB2000/000164 1999-02-05 2000-02-07 Process for preparing coagulants for water treatment WO2000046243A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU23150/00A AU2315000A (en) 1999-02-05 2000-02-07 Process for preparing coagulants for water treatment

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9902553.8A GB9902553D0 (en) 1999-02-05 1999-02-05 Process for preparing coagulants for water treatment
GB9902553.8 1999-02-05

Publications (1)

Publication Number Publication Date
WO2000046243A1 true WO2000046243A1 (en) 2000-08-10

Family

ID=10847146

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IB2000/000164 WO2000046243A1 (en) 1999-02-05 2000-02-07 Process for preparing coagulants for water treatment

Country Status (3)

Country Link
AU (1) AU2315000A (en)
GB (1) GB9902553D0 (en)
WO (1) WO2000046243A1 (en)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001074843A1 (en) * 2000-03-31 2001-10-11 Optima Environnement S.A. Process for preparing coagulants for water treatment
WO2003008441A2 (en) * 2001-07-19 2003-01-30 Optima Environnement S.A. Moringa seed proteins
CN102674517A (en) * 2012-05-23 2012-09-19 大理学院 Method for rapidly flocculating blue-green algae in water body
WO2022013548A1 (en) * 2020-07-13 2022-01-20 The University Court Of The University Of Aberdeen Coated food product for controlled release and improved performance

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106800586A (en) * 2017-01-22 2017-06-06 嵊州市派特普科技开发有限公司 A kind of method of Moringa protein high efficiency extraction
CN108675366A (en) * 2018-05-30 2018-10-19 佛山市航祥千安科技有限公司 A kind of plant compounding water purification agent

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
ANSELME NDABIGENGESERE ET AL: "ACTIVE AGENTS AND MECHANISM OF COAGULATION OF TURBID WATERS USING MORINGA OLEIFERA", WATER RESEARCH,NL,ELSEVIER SCIENCE PUBLISHERS, AMSTERDAM, vol. 29, no. 2, 1 February 1995 (1995-02-01), pages 703 - 710, XP000484752, ISSN: 0043-1354 *
OKUDA T ET AL: "Improvement of extraction method of coagulation active components from Moringa oleifera seed", WATER RESEARCH,NL,ELSEVIER SCIENCE PUBLISHERS, AMSTERDAM, vol. 33, no. 15, October 1999 (1999-10-01), pages 3373 - 3378, XP004179114, ISSN: 0043-1354 *

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001074843A1 (en) * 2000-03-31 2001-10-11 Optima Environnement S.A. Process for preparing coagulants for water treatment
US6890565B2 (en) 2000-03-31 2005-05-10 Optima Environnment S.A. Process for preparing coagulants for water treatment
WO2003008441A2 (en) * 2001-07-19 2003-01-30 Optima Environnement S.A. Moringa seed proteins
WO2003008441A3 (en) * 2001-07-19 2003-09-18 Optima Environnement S A Moringa seed proteins
CN102674517A (en) * 2012-05-23 2012-09-19 大理学院 Method for rapidly flocculating blue-green algae in water body
WO2022013548A1 (en) * 2020-07-13 2022-01-20 The University Court Of The University Of Aberdeen Coated food product for controlled release and improved performance
GB2612734A (en) * 2020-07-13 2023-05-10 The Univ Court Of The Univ Of Aberdeen Coated food product for controlled release and improved performance

Also Published As

Publication number Publication date
GB9902553D0 (en) 1999-03-24
AU2315000A (en) 2000-08-25

Similar Documents

Publication Publication Date Title
RU2741106C2 (en) Method of processing dandelion plants components
US20160222135A1 (en) System for and method of separating pure starch from grains for alcohol production using a dry mill process
CN101575371B (en) Method for adopting tannin to process silkworm cocoon processing wastewater and recycle sericin protein
JPH0848702A (en) Extracting method for soluble polysaccharide
WO2000046243A1 (en) Process for preparing coagulants for water treatment
CN102453099B (en) Preparation method of corn starch
US6890565B2 (en) Process for preparing coagulants for water treatment
CN104489602A (en) A method for preparing seafood seasonings using fishmeal processing wastewater
CN1313496C (en) Taro starch extracting method
RU2538147C1 (en) Method for processing of sunflower or rape extraction cake (versions)
WO2022139115A1 (en) Method for preparation of alginic acid and fucoidan
JP3282036B2 (en) Method for producing acidic polysaccharide
CN115477602A (en) Extraction process of astaxanthin ester in crayfish waste
CN212881194U (en) L-tyrosine splitter
CN103242440A (en) Sericin extracting method
CN111957080A (en) L-tyrosine separation equipment and L-tyrosine separation method
JPH0430401B2 (en)
JP3157528B2 (en) Improved suspension clarification
Pominski et al. Production of peanut protein
US20120302735A1 (en) Production of soy protein product
RU2178708C2 (en) Method of insulin producing
JPS6157520A (en) Solution having high fucoidan purity, or preparation of fucoidan
CN101973675A (en) Method for extracting protein from fish meal processing wastewater and making wastewater up to discharge standard
CN100448362C (en) Fish soluble slurry protein powder and preparation method thereof
SU736938A1 (en) Method of obtaining protein-containing fodder

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AE AL AM AT AU AZ BA BB BG BR BY CA CH CN CR CU CZ DE DK DM EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): GH GM KE LS MW SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

122 Ep: pct application non-entry in european phase